CREATIVE MEDICAL TECHNOLOGY (CELZ)
US22529Y4089 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.29M | -10.14M | 19.21M | -36.33M | -8.48M | |||
| Depreciation Amortization | 94.58K | 90.00K | 90.00K | 70.00K | 30.00K | |||
| Change In Working Capital | -2.84M | 2.19M | 250.00K | 690.00K | 60.00K | |||
| Interest Paid | 0.00 | 0.00 | 10.00K | 10.00K | 20.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 2.56K | 70.00K | -21.77M | 35.13M | 7.18M | |||
| OPERATING CASH FLOW | -8.03M | -7.80M | -2.22M | -430.00K | -1.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -100.00K | N/A | 0.00 | N/A | N/A | |||
| Other Investing Activity | 3.55M | -10.08M | N/A | -250.00K | N/A | |||
| INVESTING CASH FLOW | 3.45M | -10.08M | 0.00 | -250.00K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -1.63M | 690.00K | 1.00M | |||
| Stock Issued/Repurchased | -270.95K | 15.47M | 15.02M | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | -550.00K | N/A | N/A | |||
| FINANCING CASH FLOW | -270.95K | 15.47M | 12.84M | 690.00K | 1.00M | |||
| CHANGE IN CASH | -4.85M | -2.41M | 10.62M | 10.00K | -220.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.03M | -7.80M | -2.22M | -430.00K | -1.21M | |||
| Capital Expenditure | -100.00K | N/A | 0.00 | N/A | N/A | |||
| FREE CASH FLOW | -8.13M | -7.80M | -2.22M | -430.00K | -1.21M | |||
All data in USD